Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 328

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Developmental roadmap for antimicrobial susceptibility testing systems

Open access
the JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing, van Belkum, Alex, Bachmann, Till T., Lüdke, Gerd, Lisby, Jan Gorm, Kahlmeter, Gunnar, Mohess, Allan, Becker, Karsten, Hays, John P., Woodford, Neil, Mitsakakis, Konstantinos, Moran-Gilad, Jacob, Vila, Jordi, Peter, Harald, Rex, John H., Dunne, Wm. Michael·2019·Nature Reviews Microbiology

Abstract

Antimicrobial susceptibility testing (AST) technologies help to accelerate the initiation of targeted antimicrobial therapy for patients with infections and could potentially extend the lifespan of current narrow-spectrum antimicrobials. Although conceptually new and rapid AST technologies have been described, including new phenotyping methods, digital imaging and genomic approaches, there is no single major, or broadly accepted, technological breakthrough that leads the field of rapid AST platform development. This might be owing to several barriers that prevent the timely development and implementation of novel and rapid AST platforms in health-care settings. In this Consensus Statement, we explore such barriers, which include the utility of new methods, the complex process of validating new technology against reference methods beyond the proof-of-concept phase, the legal and regulatory landscapes, costs, the uptake of new tools, reagent stability, optimization of target product profiles, difficulties conducting clinical trials and issues relating to quality and quality control, and present possible solutions. This Consensus Statement presents the barriers that currently prevent the timely development and implementation of novel and rapid antimicrobial susceptibility testing platforms, including the costs involved, uptake of new tools, legal and regulatory aspects, difficulties conducting clinical trials and quality control, and presents possible solutions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41579-018-0098-9

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 328

Metadata

Authors
the JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing, van Belkum, A., Bachmann, T. T., Lüdke, G., Lisby, J. G., Kahlmeter, G., Mohess, A., Becker, K., Hays, J. P., Woodford, N., Mitsakakis, K., Moran-Gilad, J., Vila, J., Peter, H., Rex, J. H., & Dunne, W. M.
Venue
Nature Reviews Microbiology
Published
2018-10-17
Volume
17
Issue
1
Pages
51-62
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W2897336185
Cited by
328
References
58
FWCI
4.74
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Developmental roadmap for antimicrobial susceptibility testing systems. https://app.cochat.ai/papers/10.1038/s41579-018-0098-9
The paper
the JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing, van Belkum, A., Bachmann, T. T., Lüdke, G., Lisby, J. G., Kahlmeter, G., Mohess, A., Becker, K., Hays, J. P., Woodford, N., Mitsakakis, K., Moran-Gilad, J., Vila, J., Peter, H., Rex, J. H., & Dunne, W. M. (2019). Developmental roadmap for antimicrobial susceptibility testing systems. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-018-0098-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.